Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now full pipeline small index

Trichomonas Vaginitis: full-pipeline trial registry

1 of 3 indexed Trichomonas Vaginitis trials are currently recruiting.

Corpus placement: #5,209 of 28,707 conditions by registered trial count.

3 US clinical trials · 1 currently recruiting · #5,209 of 28,707 conditions by registered trial count

Trichomonas Vaginitis: 3 US clinical trials tracked, 1 recruiting.

Trichomonas Vaginitis is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 1 in Phase 1-2 (earlier-stage). The most active sponsor is Tulane University, running 1 of these trials.

Enrollment posture brief

Registry condition trichomonas-vaginitis

OPEN 1 | RECR 33% | LATE 1 | EARLY 1 | RANK #5209 | SPON 1

Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Trichomonas Vaginitis (this)33%
Open-enrollment share among volume-matched conditions near Trichomonas Vaginitis

Trichomonas Vaginitis lists 1 open slots (33% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Trichomonas Vaginitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Trichomonas Vaginitis is recruiting below its size-band peers.

    1 of 3 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase 21Phase 41

Phase Distribution

PhaseTrial count
Phase 2 1
Phase 4 1

Named interventions

Most-linked intervention names on Trichomonas Vaginitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Menstrual Cup Device
1 trials
Secnidazole 2000 MG Drug
1 trials
Metronidazole 500 mg Drug
1 trials

US sites by state

Facility locations filed on Trichomonas Vaginitis trials. A trial with sites in several states counts in each.

Pennsylvania 1 trials
Louisiana 1 trials
Illinois 1 trials
Florida 1 trials
Alabama 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Trichomonas Vaginitis page

3 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • 1 Trichomonas Vaginitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
  • Tulane University sponsors the most Trichomonas Vaginitis trials on record, review their full trial history before evaluating a specific study. See Tulane University's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Trichomonas Vaginitis condition card totals 3 registered trials; most-linked intervention Menstrual Cup; top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.